Metricsofthegynecologiconcologyliteraturefocusedoncitedutilization and costs

article i nfo Objective. The newest findings on literature utilization relevant to gynecologic oncology were published by Thomson Reuters during June2013 asdeterminants of journal standing. Our objective was to assess thedifferent metrics reported for relative impact and cost for journals relevant to gynecologic oncology. Methods. 55 journals were evaluated for Impact Factor (IF), 5 Year IF, Immediacy Index, Cited Half Life, Eigenfactor (EF) Score, Article Influence (AI) scores and subscription costs obtained from publisher information. Results. CA-A Cancer Journal for Clinicianshad the highest IF (101.78) & AI (24.502). The top EF cancer-specific journals were theJournalofClinicalOncology,CancerResearch,ClinicalCancerResearchandOncogene.Rankingsfor Gynecologic Oncology (409articles,18,243citations)were IF = 3.929,43/55,EF = 0.038,28/55,andAI = 1.099, 44/55, all higher than the previous year. The IF improved from the 5 year IF in 31 journals, including Gynecologic Oncology, 29/31. Subscription costs for Gynecologic Oncology compared favorably to other journals. Conclusions. The high utilization of review information inCA-A Cancer Journal for Cliniciansand Nature Review Cancer illustrated by the IF coupled with a relatively low number of articles and short cited half life indicates that they serve as a leading source of quoted cancer statistics (CA-A Cancer Journal for Clinicians). Rankings for Gynecologic Oncology and the International Journal of Gynecologic Cancer have improved. Regardless of specialty size, the Impact Factor for Gynecologic Oncology is respectably strong. The decreased IF in 44% of the journals may reflect the international economy's effect on cancer research.